From With $40M Banked, Escient Building for Fast Move to Human Trials:

Escient founders Alain Baron and Marcus Boehm (BVBigelow photo)
Escient founders Alain Baron and Marcus Boehm (BVBigelow photo)

Escient Pharmaceuticals CEO Alain Baron and CTO Marcus Boehm (BVBigelow photo)